Join
Live feed
·
INSIDERFilingvia Quantisnow
Monopar Therapeutics Inc. logo

Chief Executive Officer Robinson Chandler converted options into 9,801 shares and covered exercise/tax liability with 4,344 shares, increasing direct ownership by 5% to 104,724 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNPR (Monopar Therapeutics Inc.) and more on Quantisnow.

Chief Executive Officer Robinson Chandler converted options into 9,801 shares and covered exercise/tax liability with 4,344 shares, increasing direct ownership by 5% to 104,724 units (SEC Form 4) to satisfy withholding obligation | Quantisnow